Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -508.33% | -145.85% | -164.88% | -168.64% | -82.44% |
| Total Depreciation and Amortization | 5.51% | 6.38% | 7.28% | 4.34% | 8.55% |
| Total Amortization of Deferred Charges | -31.43% | -29.73% | -28.21% | -22.50% | -58.33% |
| Total Other Non-Cash Items | 1,700.00% | 112.09% | 109.42% | 102.14% | 98.82% |
| Change in Net Operating Assets | 35.71% | -62.18% | -17.98% | -33.56% | -129.29% |
| Cash from Operations | -2.38% | 7.87% | 7.85% | 3.51% | 20.73% |
| Capital Expenditure | 21.07% | -12.80% | -39.36% | -87.76% | -85.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -85.37% | -85.37% | -- | -- | -- |
| Divestitures | -100.00% | -100.00% | -100.00% | -99.34% | -99.34% |
| Other Investing Activities | -16.67% | -90.91% | -72.73% | 14.29% | -100.00% |
| Cash from Investing | 2.95% | -132.21% | -126.43% | -124.09% | -125.14% |
| Total Debt Issued | 299.26% | 307.67% | 232.78% | 364.21% | -5.26% |
| Total Debt Repaid | -189.53% | -3.84% | -30.66% | -42.74% | 60.39% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -157.14% | -150.00% | -169.23% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -191.43% | -201.77% | 140.00% | 170.59% | 252.17% |
| Cash from Financing | -29.07% | 79.00% | 72.26% | 81.57% | 81.93% |
| Foreign Exchange rate Adjustments | 175.00% | 246.15% | 186.05% | 178.02% | -42.86% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -366.67% | -107.32% | -141.55% | -33.62% | -87.60% |